| Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase LM Mansky, HM Temin Journal of virology 69 (8), 5087-5094, 1995 | 1543 | 1995 |
| Viral mutation rates R Sanjuán, MR Nebot, N Chirico, LM Mansky, R Belshaw Journal of virology 84 (19), 9733-9748, 2010 | 1461 | 2010 |
| Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration JL Mbisa, R Barr, JA Thomas, N Vandegraaff, IJ Dorweiler, ... Journal of virology 81 (13), 7099-7110, 2007 | 340 | 2007 |
| The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate LM Mansky, S Preveral, L Selig, R Benarous, S Benichou Journal of virology 74 (15), 7039-7047, 2000 | 231 | 2000 |
| APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis HA Sadler, MD Stenglein, RS Harris, LM Mansky Journal of virology 84 (14), 7396-7404, 2010 | 220 | 2010 |
| Retrovirus mutation rates and their role in genetic variation LM Mansky Journal of general Virology 79 (6), 1337-1345, 1998 | 208 | 1998 |
| The Mutation Rate of Human Immunodeficiency Virus Type 1 Is Influenced by thevprGene LM Mansky Virology 222 (2), 391-400, 1996 | 203 | 1996 |
| Roles of uracil-DNA glycosylase and dUTPase in virus replication R Chen, H Wang, LM Mansky Journal of General Virology 83 (10), 2339-2345, 2002 | 180 | 2002 |
| Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages R Chen, E Le Rouzic, JA Kearney, LM Mansky, S Benichou Journal of Biological Chemistry 279 (27), 28419-28425, 2004 | 171 | 2004 |
| Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line LM MANSKY AIDS research and human retroviruses 12 (4), 307-314, 1996 | 165 | 1996 |
| Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus LM Mansky, HM Temin Journal of virology 68 (1), 494-499, 1994 | 130 | 1994 |
| 5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1 MJ Dapp, CL Clouser, S Patterson, LM Mansky Journal of virology 83 (22), 11950-11958, 2009 | 117 | 2009 |
| Tenofovir-associated bone density loss IF Grigsby, L Pham, LM Mansky, R Gopalakrishnan, KC Mansky Therapeutics and Clinical Risk Management, 41-47, 2010 | 113 | 2010 |
| Exploiting drug repositioning for discovery of a novel HIV combination therapy CL Clouser, SE Patterson, LM Mansky Journal of virology 84 (18), 9301-9309, 2010 | 106 | 2010 |
| Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine CL Clouser, J Chauhan, MA Bess, JL Van Oploo, D Zhou, S Dimick-Gray, ... Bioorganic & medicinal chemistry letters 22 (21), 6642-6646, 2012 | 102 | 2012 |
| A virus-binding hot spot on human angiotensin-converting enzyme 2 is critical for binding of two different coronaviruses K Wu, L Chen, G Peng, W Zhou, CA Pennell, LM Mansky, RJ Geraghty, ... Journal of virology 85 (11), 5331-5337, 2011 | 101 | 2011 |
| 3′-Azido-3′-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1 LM Mansky, LC Bernard Journal of Virology 74 (20), 9532-9539, 2000 | 101 | 2000 |
| Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms Z Ni, DA Knorr, CL Clouser, MK Hexum, P Southern, LM Mansky, IH Park, ... Journal of virology 85 (1), 43-50, 2011 | 100 | 2011 |
| In the beginning: genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly NA Jewell, LM Mansky Journal of General Virology 81 (8), 1889-1899, 2000 | 99 | 2000 |
| In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy LM Mansky Journal of virology 74 (20), 9525-9531, 2000 | 97 | 2000 |
